Merrimack Pharmaceuticals Inc. (MACK) Climbed 7.68% or 0.48 To Price $6.73 On Monday


Merrimack Pharmaceuticals Inc. (MACK) climbed 7.68% or 0.48 to $6.73. It is around 37332 shares traded, which is 43.77% compare to the average total volume 85297. The market cap of MACK is $89.80 million. The year to date change is 61.62%. The 52 week price range is from $3.34 to $10.53. Price of MACK have changed 0.97% during last week. It have changed -10.33% over last month, 20.66% over last 3 months, 61.92% over last 6 months and -26.30% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for MACK is 6.37. It is -5.35% below current price. The 200-day Moving Averages for MACK is 5.30. It is -21.25% below current price. The 52-week High is 10.53. It is 56.46% from the current price. The 52-week Low is 3.34. It is -50.37% from current price.

There are some statistics of MACK. It is has market cap $89.80 million. The share outstanding is 13.34 million. The average volume is 85297. The percent of top 15 Institution holding is 56.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of MACK is -52.23%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of MACK is -39.35%.


Tags:

Share this post